Financhill
Sell
50

WSM Quote, Financials, Valuation and Earnings

Last price:
$158.86
Seasonality move :
6.15%
Day range:
$158.46 - $162.66
52-week range:
$125.33 - $219.98
Dividend yield:
1.48%
P/E ratio:
18.66x
P/S ratio:
2.61x
P/B ratio:
9.13x
Volume:
2M
Avg. volume:
2M
1-year change:
4.52%
Market cap:
$19.7B
Revenue:
$7.7B
EPS (TTM):
$8.60

Earnings Data

Next earnings date for WSM
Aug 22
2025
Most recent earnings per share
$1.85
Beat by $0.09
(May 22/2025)
Consensus Estimate
$1.76
(May 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

WSM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/22/2025 Q3 $1.8B -- -- $1.78 --
05/22/2025 Q2 $1.7B $1.7B $1.85 $1.76 $0.09
03/19/2025 Q1 $2.4B $2.5B $3.05 $2.94 $0.11
11/20/2024 Q4 $1.8B $1.8B $1.96 $1.77 $0.19
08/22/2024 Q3 $1.8B $1.8B $1.74 $1.61 $0.13
05/22/2024 Q2 $1.7B $1.7B $2.04 $1.37 $0.67
03/13/2024 Q1 $2.2B $2.3B $2.72 $2.58 $0.14
11/16/2023 Q4 $1.9B $1.9B $1.83 $1.67 $0.16
08/23/2023 Q3 $2B $1.9B $1.56 $1.36 $0.20
05/23/2023 Q2 $1.8B $1.8B $1.18 $1.19 -$0.02
03/16/2023 Q1 $2.6B $2.5B $2.64 $2.73 -$0.09
11/17/2022 Q4 -- $2.2B $1.86 -- --
08/24/2022 Q3 -- $2.1B $1.94 -- --
05/25/2022 Q2 -- $1.9B $1.75 -- --
03/16/2022 Q1 -- $2.5B $2.68 -- --
11/18/2021 Q4 -- $2B $1.65 -- --
08/25/2021 Q3 -- $1.9B $1.61 -- --
05/26/2021 Q2 -- $1.7B $1.45 -- --
03/17/2021 Q1 -- $2.3B $1.96 -- --
11/19/2020 Q4 -- $1.8B $1.27 -- --
08/26/2020 Q3 -- $1.5B $0.85 -- --
05/28/2020 Q2 -- $1.2B $0.23 -- --
03/18/2020 Q1 -- $1.8B $1.05 -- --
11/21/2019 Q4 -- $1.4B $0.47 -- --
08/28/2019 Q3 -- $1.4B $0.40 -- --
05/30/2019 Q2 -- $1.2B $0.33 -- --
03/20/2019 Q1 -- $1.8B $0.97 -- --
11/15/2018 Q4 -- $1.4B $0.50 -- --
08/22/2018 Q3 -- $1.3B $0.31 -- --
05/23/2018 Q2 -- $1.2B $0.27 -- --
03/14/2018 Q1 -- $1.7B $0.57 -- --
11/16/2017 Q4 -- $1.3B $0.42 -- --
08/23/2017 Q3 -- $1.2B $0.31 -- --
05/24/2017 Q2 -- $1.1B $0.23 -- --
03/15/2017 Q1 -- $1.6B $0.82 -- --
11/17/2016 Q4 -- $1.2B $0.39 -- --
08/24/2016 Q3 -- $1.2B $0.29 -- --
05/25/2016 Q2 -- $1.1B $0.22 -- --
03/16/2016 Q1 -- $1.6B $0.78 -- --
11/19/2015 Q4 -- $1.2B $0.39 -- --
08/26/2015 Q3 -- $1.1B $0.29 -- --

Williams-Sonoma Earnings Questions

  • How Much did Williams-Sonoma Generate in Revenue Last Quarter?

    Williams-Sonoma reported $1.7B worth of top line sales in its most recent quarter.

  • Did Williams-Sonoma Beat Earnings Last Quarter?

    Williams-Sonoma announced earnings per share of $1.85 which represents a beat of analyst forecast a $1.76 per share.

  • Is Williams-Sonoma Profitable?

    Williams-Sonoma reported $765.8M that represents $6.14 per share over the last quarter.

  • What is the Analyst Consensus for Williams-Sonoma EPS Next Year?

    Williams-Sonoma's earnings are forecast to decrease from $8.79 per share to $8.46 per share next year representing a decrease of -2.85%.

  • When is Williams-Sonoma's Earnings Date?

    Williams-Sonoma's next earnings date is August 22, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Take-Two Stock Go?
How High Will Take-Two Stock Go?

Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…

Where Will Target’s Stock Be in 10 Years?
Where Will Target’s Stock Be in 10 Years?

If you could hop into a time machine and land…

Why Did Stan Druckenmiller Buy DocuSign?
Why Did Stan Druckenmiller Buy DocuSign?

Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…

Stock Ideas

Buy
64
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
37
RGC alert for Jun 21

Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.

Buy
83
GMS alert for Jun 21

GMS [GMS] is up 23.79% over the past day.

Buy
57
QNTM alert for Jun 21

Quantum BioPharma [QNTM] is up 13.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock